<DOC>
	<DOCNO>NCT02523105</DOCNO>
	<brief_summary>This study evaluate use brain activity monitor early identification pharmaceutical treatment efficacy development depression deterioration event .</brief_summary>
	<brief_title>Evaluation Use Brain Activity Monitoring Evaluation Depression Treatment</brief_title>
	<detailed_description>The study conduct two arm : In arm I , participant diagnose depression . In arm II , healthy participant . Arm I - Participants need start switch pharmacological antidepressant therapy recruit . Their clinical status evaluate EEG characteristic collect . Arm II - Clinical EEG characteristic Healthy volunteer collect similar timetable .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<criteria>Participant willing able give inform consent participation study . Male Female , age 18 65 year . Able willing comply study requirement . Additional Inclusion Criteria Arm I Diagnosed depression Being within 2 day receive pharmaceutical treatment depression first time change dose change type current pharmaceutical treatment addition drug current pharmaceutical treatment . Additional Inclusion Criteria Arm II Brief Symptom Inventory ( BSI &lt; 2.3 ) . The participant may enter study ANY follow apply : Diagnosed Psychotic disorder . Diagnosed Central Neurological disorder . A user recreational illicit drug recent history drug alcohol abuse dependence . Hearing disorder and/or know ear drum impairment . High suicide risk judge research team .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>